Sanger Science

  • 11 April 2024

    Parasitic worms transmitted through the soil infect an estimated 1.5 billion people worldwide and cause diseases that help drive poverty in tropical and subtropical countries. Wellcome Sanger Institute researchers, as part of the STOP2030 project, are using their unique genetics expertise to monitor the effects of promising new treatments to help combat these diseases.

  • 21 March 202410.5 min read

    New research is focussing on understanding the genetic causes of acral melanoma - an understudied disease that is the most common type of melanoma in Mexico. 

  • 15 February 202421.4 min read

    We spoke to Jyoti Nangalia, a researcher at the forefront of innovation in blood cancers. She is combining her clinical and academic expertise to bring better diagnosis tools for patients and clinicians.

  • 6 February 202410.8 min read

    Three vaccine targets discovered by the Wellcome Sanger Institute focus on targeting animal trypanosomiasis in an effort to find a cure for a disease that causes billions in economic losses in one of the poorest regions on earth. These losses fall heavily on small holders, who are often heavily dependent on livestock for their livelihood.

  • 29 January 202432.7 min read

    Meet the four winners of our Sanger Accelerator Awards for Postdocs (SAAPs) to accelerate postdocs along their career trajectory

  • 18 January 20245 min read

    A recent hackathon, hosted by the Wellcome Sanger Institute, brought together software developers and computational biologists working on tools to analyse data from single cells.

  • 16 January 202421.4 min read

    The Atlas of Variant Effects Alliance celebrates its fourth year this month.  A collaboration of multiple institutes, including the Wellcome Sanger Institute, the Alliance has the aim of assessing the effects of all variants in our genomes. In this blog, we highlight the Alliance’s achievements and the diverse community underpinning such a colossal effort.

  • 13 December 20237.8 min read

    Haerin Jang is analysing genetic data from lupus patients to understand why there are such big differences between people are affected by the disease.